Nanome is a San Francisco-based publisher that specializes in immersive molecular visualization and collaborative drug-discovery software. Its flagship platform combines virtual-reality environments with cloud-based AI assistance, enabling medicinal chemists, structural biologists, and crystallographers to inspect protein-ligand complexes, modify scaffolds in real time, and share synchronized sessions with colleagues across the globe. Typical use cases range from early-stage hit identification—where researchers manipulate 3-D structures to spot binding pockets—to lead-optimization workshops that require rapid iteration on hydrogen-bond networks or solubility tweaks. The software supports standard file formats such as PDB, SDF, and MOL2, integrates force-field minimization engines, and streams data to VR headsets, desktop PCs, or flat-screen laptops so teams can choose the level of immersion that suits their hardware budget. Because calculations run on remote GPUs, even lightweight notebooks can render multi-million-atom antibody assemblies at 90 fps, while built-in speech-to-text logging and snapshot tools create audit trails for regulatory submissions. Nanome’s multi-user spatial computing layer further reduces design cycles by letting remote collaborators point, annotate, and vote on chemical modifications as if they were standing around the same bench. The publisher’s software is available for free on get.nero.com, with downloads delivered through trusted Windows package sources such as winget that always install the latest release and allow batch deployment of multiple applications.

Nanome

AI assisted scientific copilot + multi-user spatial computing to accelerate scientific discovery drug discovery.

Details